Italian Orthopaedic and Traumatology Society (SIOT) position statement on the non-surgical management of knee osteoarthritis.
Knee OA
Non-surgical management
Osteoarthritis
SIOT position statement
Journal
Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology
ISSN: 1590-9999
Titre abrégé: J Orthop Traumatol
Pays: Italy
ID NLM: 101090931
Informations de publication
Date de publication:
07 Sep 2023
07 Sep 2023
Historique:
received:
23
03
2023
accepted:
15
08
2023
medline:
11
9
2023
pubmed:
8
9
2023
entrez:
7
9
2023
Statut:
epublish
Résumé
Knee osteoarthritis (OA) is a chronic disease associated with a severe impact on quality of life. However, unfortunately, there are no evidence-based guidelines for the non-surgical management of this disease. While recognising the gap between scientific evidence and clinical practice, this position statement aims to present recommendations for the non-surgical management of knee OA, considering the available evidence and the clinical knowledge of experienced surgeons. The overall goal is to offer an evidenced-based expert opinion, aiding clinicians in the management of knee OA while considering the condition, values, needs and preferences of individual patients. The study design for this position statement involved a preliminary search of PubMed, Google Scholar, Medline and Cochrane databases for literature spanning the period between January 2021 and April 2023, followed by screening of relevant articles (systematic reviews and meta-analyses). A Società Italiana Ortopedia e Traumatologia (SIOT) multidisciplinary task force (composed of four orthopaedic surgeons and a rheumatologist) subsequently formulated the recommendations. Evidence-based recommendations for the non-surgical management of knee OA were developed, covering assessment, general approach, patient information and education, lifestyle changes and physical therapy, walking aids, balneotherapy, transcutaneous electrical nerve stimulation, pulsed electromagnetic field therapy, pharmacological interventions and injections. For non-surgical management of knee OA, the recommended first step is to bring about lifestyle changes, particularly management of body weight combined with physical exercise and/or hydrotherapy. For acute symptoms, non-steroidal anti-inflammatory drugs (NSAIDs), topic or oral, can be used. Opioids can only be used as third-line pharmacological treatment. Glucosamine and chondroitin are also suggested as chronic pharmacological treatment. Regarding intra-articular infiltrative therapy, the use of hyaluronic acid is recommended in cases of chronic knee OA [platelet-rich plasma (PRP) as second line), in the absence of active acute disease, while the use of intra-articular injections of cortisone is effective and preferred for severe acute symptoms.
Sections du résumé
BACKGROUND
BACKGROUND
Knee osteoarthritis (OA) is a chronic disease associated with a severe impact on quality of life. However, unfortunately, there are no evidence-based guidelines for the non-surgical management of this disease. While recognising the gap between scientific evidence and clinical practice, this position statement aims to present recommendations for the non-surgical management of knee OA, considering the available evidence and the clinical knowledge of experienced surgeons. The overall goal is to offer an evidenced-based expert opinion, aiding clinicians in the management of knee OA while considering the condition, values, needs and preferences of individual patients.
METHODS
METHODS
The study design for this position statement involved a preliminary search of PubMed, Google Scholar, Medline and Cochrane databases for literature spanning the period between January 2021 and April 2023, followed by screening of relevant articles (systematic reviews and meta-analyses). A Società Italiana Ortopedia e Traumatologia (SIOT) multidisciplinary task force (composed of four orthopaedic surgeons and a rheumatologist) subsequently formulated the recommendations.
RESULTS
RESULTS
Evidence-based recommendations for the non-surgical management of knee OA were developed, covering assessment, general approach, patient information and education, lifestyle changes and physical therapy, walking aids, balneotherapy, transcutaneous electrical nerve stimulation, pulsed electromagnetic field therapy, pharmacological interventions and injections.
CONCLUSIONS
CONCLUSIONS
For non-surgical management of knee OA, the recommended first step is to bring about lifestyle changes, particularly management of body weight combined with physical exercise and/or hydrotherapy. For acute symptoms, non-steroidal anti-inflammatory drugs (NSAIDs), topic or oral, can be used. Opioids can only be used as third-line pharmacological treatment. Glucosamine and chondroitin are also suggested as chronic pharmacological treatment. Regarding intra-articular infiltrative therapy, the use of hyaluronic acid is recommended in cases of chronic knee OA [platelet-rich plasma (PRP) as second line), in the absence of active acute disease, while the use of intra-articular injections of cortisone is effective and preferred for severe acute symptoms.
Identifiants
pubmed: 37679552
doi: 10.1186/s10195-023-00729-z
pii: 10.1186/s10195-023-00729-z
pmc: PMC10485223
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
47Informations de copyright
© 2023. Societa Italiana di Ortopedia e Traumatologia (Italian Society of Orthopaedics and Traumatology SIOT).
Références
Curr Med Res Opin. 2015 May;31(5):1041-5
pubmed: 25753599
Clin J Pain. 2016 Feb;32(2):146-54
pubmed: 25803757
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Ther Clin Risk Manag. 2021 May 28;17:507-530
pubmed: 34093017
Drugs Aging. 2019 Apr;36(Suppl 1):65-99
pubmed: 31073924
J Orthop Traumatol. 2022 Feb 5;23(1):7
pubmed: 35122541
Acta Clin Croat. 2019 Jun;58(Suppl 1):53-61
pubmed: 31741560
Drugs Aging. 2016 Feb;33(2):75-85
pubmed: 26849131
Aging Clin Exp Res. 2018 Feb;30(2):111-117
pubmed: 29177637
Clin Rheumatol. 2018 Sep;37(9):2517-2527
pubmed: 29796866
Osteoarthritis Cartilage. 2014 Mar;22(3):363-88
pubmed: 24462672
Osteoarthritis Cartilage. 2008 Feb;16(2):137-62
pubmed: 18279766
Orthop J Sports Med. 2021 Aug 31;9(8):23259671211030272
pubmed: 34485586
Osteoarthritis Cartilage. 2019 Nov;27(11):1578-1589
pubmed: 31278997
Am J Sports Med. 2021 Feb;49(2):487-496
pubmed: 33523756
Osteoarthritis Cartilage. 2007 Sep;15(9):981-1000
pubmed: 17719803
Cochrane Database Syst Rev. 2013 Dec 14;(12):CD003523
pubmed: 24338431
Int J Surg. 2017 Mar;39:95-103
pubmed: 28137554
Semin Arthritis Rheum. 2014 Dec;44(3):253-63
pubmed: 24953861
Arthritis Care Res (Hoboken). 2020 Feb;72(2):149-162
pubmed: 31908149
Cochrane Database Syst Rev. 2018 Apr 17;4:CD010842
pubmed: 29664187
J Bone Miner Res. 2020 Dec;35(12):2318-2326
pubmed: 32662919
Ann Phys Rehabil Med. 2016 Jun;59(3):216-226
pubmed: 26996955
Drug Des Devel Ther. 2018 Mar 05;12:445-453
pubmed: 29551888
J Biol Regul Homeost Agents. 2019 Oct 08;33(5):1315-1320
pubmed: 31591875
Int J Mol Sci. 2017 Dec 13;18(12):
pubmed: 29236045
Rheumatology (Oxford). 2015 Oct;54(10):1826-32
pubmed: 25998450
BMC Musculoskelet Disord. 2021 Feb 3;22(1):134
pubmed: 33536010
Semin Arthritis Rheum. 2014 Jun;43(6):701-12
pubmed: 24387819
Arthroscopy. 2020 Jan;36(1):277-286
pubmed: 31679646
Arthritis Care Res (Hoboken). 2012 Apr;64(4):465-74
pubmed: 22563589
Nat Rev Rheumatol. 2021 Jan;17(1):59-66
pubmed: 33116279
J Orthop Traumatol. 2022 Feb 7;23(1):8
pubmed: 35129728
Cochrane Database Syst Rev. 2015 Oct 22;(10):CD005328
pubmed: 26490760
Wien Klin Wochenschr. 2022 Jun;134(11-12):425-433
pubmed: 35362792
BMJ Open. 2018 Dec 14;8(12):e022879
pubmed: 30552258
Ann Rheum Dis. 2013 Jul;72(7):1125-35
pubmed: 23595142
Best Pract Res Clin Rheumatol. 2020 Apr;34(2):101564
pubmed: 32773214
Drugs. 2020 Dec;80(18):1947-1959
pubmed: 33074440
J Clin Diagn Res. 2017 Sep;11(9):UC01-UC03
pubmed: 29207809
Aging Clin Exp Res. 2020 Apr;32(4):547-560
pubmed: 32170710
J Rheumatol. 2019 Aug;46(8):981-989
pubmed: 30647185
J Orthop Surg Res. 2020 Sep 11;15(1):403
pubmed: 32912243
Biomed Res Int. 2018 Jun 25;2018:1042576
pubmed: 30046586
Osteoarthritis Cartilage. 2015 Feb;23(2):189-202
pubmed: 25497083
Acta Reumatol Port. 2019 Jul 29;44(3):173-217
pubmed: 31356585
Rheumatol Int. 2018 Oct;38(10):1807-1824
pubmed: 29947999
Curr Sports Med Rep. 2011 Sep-Oct;10(5):279-84
pubmed: 23531974
Pharmaceuticals (Basel). 2021 Mar 02;14(3):
pubmed: 33801304
Expert Opin Biol Ther. 2020 Dec;20(12):1447-1460
pubmed: 32692595
Rev Bras Med. 1957 May;14(5):319-22
pubmed: 13466288
PLoS One. 2013 Sep 04;8(9):e72714
pubmed: 24023766